NCT04926285 2026-03-16
VEN-OM
University of Illinois at Chicago
Phase 1 Completed
Clinical Trials
3 trialsNCT02141477 2018-02-13
Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01844869 2015-01-30
An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Completed